ModivioBio is a leading contract research organization (CRO) dedicated to advancing preclinical research for the global scientific community. We deliver innovative, high-quality solutions that help researchers and biopharmaceutical partners accelerate scientific discovery and new radiotracers development.
Why choose ModivioBio
At ModivioBio, we combine scientific excellence, advanced imaging technologies, and deep expertise in translational research to deliver high-quality preclinical data that supports confident decision-making in drug development.
We specialize in preclinical imaging, data processing, and quantitative analysis in animal models, leveraging advanced PET, MRI and Autoradiography technologies. Our experienced scientific team designs and executes rigorous preclinical studies tailored to each client’s research objectives
Scientific Leadership
Our organization is led by internationally recognized scientists whose work has significantly contributed to the advancement of preclinical imaging and biomedical research. Our Scientific Advisory Board and founder have collectively authored more than 740 peer-reviewed publications, reflecting decades of scientific innovation and leadership.